The Vertical Group is a private equity and venture capital firm established in 1988, with headquarters in Berkeley Heights, New Jersey, and an additional office in San Mateo, California. The firm specializes in providing growth capital and financing to early-stage and late-stage companies, particularly in the medical technology and biotechnology sectors. Its investment strategy includes buyouts, recapitalizations, and public investments, with typical investment amounts ranging from $0.25 million to over $10 million, and a preference for holding investments for ten years or longer. The Vertical Group is not limited by transaction type or company size, allowing for a flexible approach to its investment activities.
MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating neurological disorders. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation to address conditions such as tinnitus, chronic pain, and rehabilitation following strokes. Its flagship product, Vivistim, has received FDA approval for use in ischemic stroke survivors experiencing moderate to severe upper limb impairment. MicroTransponder's innovative approaches, which include paired vagus nerve stimulation and wireless neurostimulation systems, are designed to enhance recovery and improve quality of life for patients facing various neurological challenges.
Route 92
Series F in 2023
Route 92 Medical is a medical device company founded in 2015 and based in San Mateo, California. The company specializes in developing innovative solutions for stroke treatment, focusing on a stealthy catheter designed for acute ischemic stroke. Their technology includes a percutaneous catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery mechanism. These advancements aim to assist healthcare professionals in effectively treating stroke patients and enhancing their recovery outcomes.
ProteinSimple
Series F in 2010
ProteinSimple, part of the Protein Platforms division of Bio-Techne, specializes in innovative protein analysis tools that assist researchers in understanding proteins and their roles in disease. The company offers a diverse range of products, including immunoassay systems for quantifying protein expression and systems designed to assess the structure and purity of protein-based therapeutics. Their nano-proteomic analysis systems focus on resolving protein analysis issues, enabling life science researchers to measure phosphor-protein signaling and activation in small biological samples. These tools allow for the quantification of phosphor-protein isoforms in various cell types, including primary and sorted stem cells, and facilitate the monitoring of drug actions in tissue sections and fine needle aspirates. ProteinSimple's solutions are vital for advancing research in the life sciences globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.